Moa Egelberg

Low levels of WRAP53 predict decreased efficacy of radiotherapy and are prognostic for local recurrence and death from breast cancer: a long-term follow-up of the SweBCG91RT randomized trial.

P. Bendahl, F. Killander, E. Holmberg, 2023, Molecular Oncology.